IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
IQVIA Holdings Inc.NYSE: IQV
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity rises 8.9% from a year ago
Total equity stood at $6.3B at the end of Q2 FY2026, up 8.9% from a year earlier and down 0.8% from the prior quarter. Over 3 fiscal years it compounded at +4.8% a year.
Context
- Total equity amounted to 21.1% of total assets at the end of Q2 FY2026, up 0.9 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +8.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 6.63B USD
- Year-over-year change
- +9.3%
- 4-year CAGR
- +2.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.63B | +9.3% |
| FY2024 | 2024-12-31 | 6.07B | -0.7% |
| FY2023 | 2023-12-31 | 6.11B | +6.0% |
| FY2022 | 2022-12-31 | 5.77B | -4.6% |
| FY2021 | 2021-12-31 | 6.04B | — |
Total Equity vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's Jun 2026 total equity of $6.3B is the 3rd highest of the 9 companies compared; the peer median is $800.99M.
- Its year-over-year change of +8.9% is the 3rd highest of 9, against a peer median of -4.0%.
- Total equity amounts to 21.1% of total assets for IQV, versus a peer median of 35.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.38B | -1.9% | +2.7% | 57.2% | |
| Jul 2026 | $7.43B | +11.9% | +24.7% | 82.0% | |
| Jun 2026 | $6.3B | +8.9% | +4.8% | 21.1% | |
| Jun 2026 | $2.85B | -16.3% | +2.0% | 37.8% | |
| Mar 2026 | $1.02B | -6.2% | -0.5% | 67.8% | |
| Sep 2026 | $584.94M | +99.2% | +5.9% | 25.4% | |
FTREFortrea Holdings Inc. | Jun 2026 | $524.2M | -11.0% | -44.8% | 19.3% |
| Sep 2026 | $500.4M | -1.5% | — | 20.4% | |
| Mar 2026 | $138.15M | -63.3% | -16.7% | 33.5% | |
| Peer median (excluding IQV) | $800.99M | -4.0% | +2.0% | 35.6% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.37B | 1.22B | 1.38B | 1.7B | 1.98B |
| Short-term Investments | 111M | 93M | 120M | 141M | 161M |
| Net Receivables | 2.61B | 2.96B | 3.41B | 3.24B | 3.43B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 521M | 561M | 546M | 592M | 519M |
| Total Current Assets | 4.76B | 4.98B | 5.6B | 5.83B | 6.25B |
| Property, Plant & Equipment (Net) | 903M | 863M | 819M | 773M | 823M |
| Goodwill | 13.3B | 13.92B | 14.57B | 14.71B | 16.62B |
| Intangible Assets | 4.94B | 4.82B | 4.84B | 4.5B | 4.96B |
| Long-term Investments | 164M | 162M | 239M | 374M | 432M |
| Tax Assets | 124M | 118M | 166M | 194M | 357M |
| Other Non-current Assets | 491M | 472M | 455M | 520M | 505M |
| Total Non-current Assets | 19.93B | 20.36B | 21.09B | 21.07B | 23.7B |
| Total Assets | 24.69B | 25.34B | 26.68B | 26.9B | 29.94B |
| Account Payables | 621M | 645M | 709M | 736M | 3.75B |
| Short-term Debt | 91M | 152M | 718M | 1.15B | 1.84B |
| Tax Payables | 137M | 161M | 116M | 156M | 0 |
| Deferred Revenue | 1.83B | 1.8B | 1.8B | 1.78B | 2.12B |
| Other Current Liabilities | 1.15B | 1.13B | 1.26B | 1.1B | 489M |
| Total Current Liabilities | 5.24B | 5.58B | 6.49B | 6.96B | 8.34B |
| Long-term Debt | 12.03B | 12.6B | 12.96B | 12.84B | 14.11B |
| Deferred Tax Liabilities | 410M | 464M | 202M | 196M | 179M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 649M | 671M | 698M | 668M | 463M |
| Total Non-current Liabilities | 13.41B | 13.99B | 14.08B | 13.88B | 14.98B |
| Total Liabilities | 18.65B | 19.57B | 20.57B | 20.83B | 23.31B |
| Common Stock | 3M | 10.9B | 3M | 3M | 11.38B |
| Retained Earnings | 2.24B | 3.33B | 4.69B | 6.07B | 7.43B |
| Accumulated OCI | (406M) | (727M) | (867M) | (1.04B) | (943M) |
| Other Stockholders Equity | 0 | (10.9B) | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 127M |
| Total Equity | 6.04B | 5.77B | 6.11B | 6.07B | 6.63B |
| Total Debt | 12.44B | 13.01B | 13.9B | 14.16B | 16.17B |
| Net Debt | 11.07B | 11.8B | 12.52B | 12.45B | 14.19B |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.